The substantial outperformance of Ascendis Pharma over the past decade, as highlighted by its impressive annualized return of 55.34%, is likely to attract investor attention and potentially drive short-term interest and investment in ASND stock. The historical performance demonstrates the company's strong growth and may be seen as a positive indicator by investors.